Literature DB >> 15356174

Accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice.

Sherry D Fleming1, Marc Monestier, George C Tsokos.   

Abstract

Natural Abs have been implicated in initiating mesenteric ischemia/reperfusion (I/R)-induced tissue injury. Autoantibodies have affinity and self-Ag recognition patterns similar to natural Abs. We considered that autoimmunity-prone mice that express high titers of autoantibodies should have enhanced I/R-induced injury. Five-month-old B6.MRL/lpr mice displayed accelerated and enhanced intestinal I/R-induced damage compared with 2-mo-old B6.MRL/lpr and age-matched C57BL/6 mice. Similarly, older autoimmune mice had accelerated remote organ (lung) damage. Infusion of serum IgG derived from 5-mo-old but not 2-mo-old B6.MRL/lpr into I/R resistant Rag-1-/- mice rendered them susceptible to local and remote organ injury. Injection of monoclonal IgG anti-DNA and anti-histone Abs into Rag-1-/- mice effectively reconstituted tissue injury. These data show that like natural Abs, autoantibodies, such as anti-dsDNA and anti-histone Abs, can instigate I/R injury and suggest that they are involved in the development of tissue damage in patients with systemic lupus erythematosus. Copyright 2004 The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356174     DOI: 10.4049/jimmunol.173.6.4230

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  TLR4-mediated Cox-2 expression increases intestinal ischemia/reperfusion-induced damage.

Authors:  Tiffany Moses; Lynn Wagner; Sherry D Fleming
Journal:  J Leukoc Biol       Date:  2009-06-29       Impact factor: 4.962

2.  IL-17A Produced by Innate Lymphoid Cells Is Essential for Intestinal Ischemia-Reperfusion Injury.

Authors:  Mayya Geha; Maria G Tsokos; Robin E Bosse; Tatyana Sannikova; Yoichiro Iwakura; Jurandir J Dalle Lucca; Rene De Waal Malefyt; George C Tsokos
Journal:  J Immunol       Date:  2017-09-06       Impact factor: 5.422

3.  Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.

Authors:  Carl Atkinson; Hongbin Song; Bo Lu; Fei Qiao; Tara A Burns; V Michael Holers; George C Tsokos; Stephen Tomlinson
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

Review 4.  Interleukin-17 and systemic lupus erythematosus: current concepts.

Authors:  A Nalbandian; J C Crispín; G C Tsokos
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

5.  IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice.

Authors:  Colin Edgerton; José C Crispín; Chantal M Moratz; Estelle Bettelli; Mohamed Oukka; Milomir Simovic; Athina Zacharia; Ryan Egan; Jie Chen; Jurandir J Dalle Lucca; Yuang-Taung Juang; George C Tsokos
Journal:  Clin Immunol       Date:  2008-12-05       Impact factor: 3.969

Review 6.  Cytokine overproduction, T-cell activation, and defective T-regulatory functions promote nephritis in systemic lupus erythematosus.

Authors:  Marco Tucci; Stefania Stucci; Sabino Strippoli; Francesco Silvestris
Journal:  J Biomed Biotechnol       Date:  2010-06-29

7.  TLR9 is dispensable for intestinal ischemia/reperfusion-induced tissue damage.

Authors:  Emily Archer Slone; Michael R Pope; Mary Roth; Ruth Welti; Sherry D Fleming
Journal:  Am J Clin Exp Immunol       Date:  2012

8.  B cells contribute to ischemia/reperfusion-mediated tissue injury.

Authors:  Jie Chen; José C Crispín; Thomas F Tedder; Jurandir Dalle Lucca; George C Tsokos
Journal:  J Autoimmun       Date:  2009-04-01       Impact factor: 7.094

9.  A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury.

Authors:  Yuxiang Huang; Fei Qiao; Carl Atkinson; V Michael Holers; Stephen Tomlinson
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

10.  Complement component C5a mediates hemorrhage-induced intestinal damage.

Authors:  Sherry D Fleming; Lauren M Phillips; John D Lambris; George C Tsokos
Journal:  J Surg Res       Date:  2008-03-13       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.